Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans
Condition: Crimean-Congo Hemorrhagic Fever Interventions: Biological: KIRIM-KONGO-VAX; Other: Placebo Sponsors: Tubitak; MonitorCRO Active, not recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials